Head-To-Head Contrast: Green Thumb Industries (OTCMKTS:GTBIF) vs. Nova Eye Medical (OTCMKTS:ELXMF)

Green Thumb Industries (OTCMKTS:GTBIF) and Nova Eye Medical (OTCMKTS:ELXMF) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Profitability

This table compares Green Thumb Industries and Nova Eye Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Green Thumb Industries	10.48%	6.03%	4.09%
Nova Eye Medical	N/A	N/A	N/A

Earnings & Valuation

This table compares Green Thumb Industries and Nova Eye Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Green Thumb Industries	$1.18 billion	1.28	$114.15 million	$0.54	14.23
Nova Eye Medical	N/A	N/A	N/A	$0.01	1.96

Green Thumb Industries has higher revenue and earnings than Nova Eye Medical. Nova Eye Medical is trading at a lower price-to-earnings ratio than Green Thumb Industries, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and target prices for Green Thumb Industries and Nova Eye Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Green Thumb Industries	0	1	1	1	3.00
Nova Eye Medical	0	0	0	0	0.00

Green Thumb Industries currently has a consensus target price of $18.00, suggesting a potential upside of 134.31%. Given Green Thumb Industries’ stronger consensus rating and higher possible upside, analysts plainly believe Green Thumb Industries is more favorable than Nova Eye Medical.

Insider & Institutional Ownership

0.1% of Green Thumb Industries shares are owned by institutional investors. Comparatively, 12.4% of Nova Eye Medical shares are owned by institutional investors. 9.4% of Green Thumb Industries shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Green Thumb Industries beats Nova Eye Medical on 11 of the 12 factors compared between the two stocks.

About Green Thumb Industries

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

About Nova Eye Medical

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.